Science Explorer Interactive view Map
Hospital / health system · Berlin · ??

Arzneimittelkommission der deutschen Ärzteschaft

Research works
65
▲ 67% vs 2013–17
Citations
1.2k
18.8 per fractional work
Top-10% rate
13.7%
record average 16.5%
Open access
16%
world 28%

Not ranked overall: Arzneimittelkommission der deutschen Ärzteschaft is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.33× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 19.40× its world share, 2 worksImmunology and Micro…Neuroscience: 0.67× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.99× its world share, 0 worksPharmacology, Toxico…Mathematics: 0.74× its world share, 0 worksMathematicsDentistry: 3.60× its world share, 0 worksDentistryHealth Professions: 2.23× its world share, 1 worksHealth ProfessionsMedicine: 2.71× its world share, 5 worksMedicineEconomics, Econometrics and Finance: 6.67× its world share, 1 worksEconomics, Econometr…Psychology: 0.80× its world share, 0 worksPsychologyworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 19.4×. Every wedge is a field page.

Which keywords describe research at Arzneimittelkommission der deutschen Ärzteschaft?

By fractional works in all years, weighted toward what it does more of than the world: Clinical Trials, Adverse Drug Reactions, Medication Adherence, Drug Development, Off-Label Drug Use, Pediatric Pharmacokinetics, Pharmaceutical Industry and Quality of Life.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Clinical Trials10▲ 25×9 topics
  2. Adverse Drug Reactions8▲ 190×2 topics
  3. Medication Adherence7▲ 174×2 topics
  4. Drug Development6▲ 69×2 topics
  5. Off-Label Drug Use6▲ 257×1 topic
  6. Pediatric Pharmacokinetics6▲ 257×1 topic
  7. Quality of Life5▲ 5.8×7 topics
  8. Pharmaceutical Industry5▲ 191×2 topics
  9. Cost-effectiveness Analysis4▲ 79×1 topic
  10. Health Utility Measures4▲ 79×1 topic
  11. Inflammation4▲ 2.6×14 topics
  12. Drug Development Costs4▲ 225×1 topic
  13. Generic Drugs4▲ 225×1 topic
  14. Medical Ethics3▲ 30×4 topics
  15. Monoclonal Antibodies3▲ 34×2 topics
  16. Biosimilars3▲ 288×1 topic
  17. Immunogenicity3▲ 84×1 topic
  18. Clinical Guidelines3▲ 13×4 topics
  19. Chemotherapy2▲ 5.1×8 topics
  20. Informed Consent2▲ 41×2 topics
  21. Public Health2▲ 2.6×6 topics
  22. Treatment Guidelines2▲ 17×3 topics
  23. Depression2▲ 4.3×9 topics
  24. Genetics2▲ 4.2×7 topics
  25. End-of-Life Care2▲ 21×2 topics
  26. Patient Rights2▲ 31×2 topics
  27. Pharmacovigilance2▲ 233×1 topic
  28. Signal Detection2▲ 233×1 topic
  29. Chronic Diseases2▲ 9.8×2 topics
  30. Healthcare Law2▲ 113×1 topic
  31. Reproductive Medicine2▲ 113×1 topic
  32. Healthcare Utilization2▲ 34×2 topics
  33. Germany2▲ 80×1 topic
  34. Health Surveys2▲ 80×1 topic
  35. Quality Assessment2▲ 13×2 topics
  36. Guideline Development2▲ 80×1 topic
  37. Practice Recommendations2▲ 80×1 topic
  38. Cognitive Function1▲ 11×3 topics
  39. Neuroimaging1▲ 7.6×3 topics
  40. Publication Bias1▲ 41×2 topics

Which research topics does Arzneimittelkommission der deutschen Ärzteschaft publish most on?

By volume in 2022–2025: Pharmaceutical Economics and Policy, Pharmaceutical studies and practices, Chronic Lymphocytic Leukemia Research and Biosimilars and Bioanalytical Methods.

  1. 1 Pharmaceutical Economics and Policy Economics and Econometrics 1 works
  2. 2 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 1 works
  3. 3 Chronic Lymphocytic Leukemia Research Genetics 1 works
  4. 4 Biosimilars and Bioanalytical Methods Immunology 0 works
  5. 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  6. 6 Immunodeficiency and Autoimmune Disorders Immunology 0 works
  7. 7 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  8. 8 Immune Cell Function and Interaction Immunology 0 works
  9. 9 Cancer Immunotherapy and Biomarkers Oncology 0 works
  10. 10 Treatment of Major Depression Pharmacology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available16.2%not open83.8%

World: 28% of research is openly available.

with international co-authors10.6%domestic only89.4%

World: 19% is written across borders.

How has Arzneimittelkommission der deutschen Ärzteschaft's research output changed?

Output in 2018–2022 was 67% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Berlin

All research institutions in Berlin

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.